The 2025 PQA Annual Meeting poster session featured 19 quality improvement and research projects. The session provided an opportunity for authors to showcase their work and for attendees to engage in insightful dialogue about healthcare quality.
PQA members and health care quality professionals gathered in Tampa, Fla., May 19-21, for the 2025 PQA Annual Meeting.
The 2025 PQA Annual Meeting poster session will showcase 19 quality improvement and research projects. This session provides authors a venue to exhibit their work and enables attendees to engage in insightful discussions about health care quality.
With the volatility and uncertainty of today’s market, we’re all watching budgets and expenditures closely.
PQA is dedicated to improving safe, effective and appropriate medication use and addressing issues that impact a person’s ability to access and use medications.
Only about five percent of rare diseases have treatments that are approved by the FDA, but the situation is improving. Today, drugs designed to treat rare diseases make up half of new drug approvals each year.
PQA has published more than 60 blogs this year, providing insights and updates on our work to improve medication use quality. As we close out 2024, here’s a look back at the top five blogs of the year.
As we near the end of 2024, it’s a great time to reflect on our accomplishments. We are wrapping up year four of Blueprint PQA 2025, PQA’s five-year strategic plan.
As we near the end of 2024, it’s a great time to reflect on our accomplishments. We are wrapping up year four of Blueprint PQA 2025, PQA’s five-year strategic plan.
As a PQA MPH Practicum Program student this summer, I collaborated with the Performance Measurement and Research Team to learn about PQA’s various frameworks and initiatives. As a dual-degree student pursuing my Doctor of Pharmacy (PharmD) and Master of Public Health (MPH), I found my background and interests to be greatly aligned with PQA. The practicum experience enriched my understanding of measure development through its iterative lifecycle and illuminated how PQA’s efforts positively impact pharmacy services like medication therapy management (MTM).
PQA members gathered in Arlington, Va., November 7-8, 2024, for the 2024 PQA Leadership Summit. The summit focused on PQA's recent and ongoing work to develop standard pharmacy quality measures.
PQA members and health quality professionals gathered in Arlington, Va., on November 7 for PQA Convenes: Quality Medication Use in Rare Disease. This half-day event brought together health care quality experts, rare disease leaders and individuals with lived experience to discuss what constitutes high-quality rare disease medication use.
What an exciting year it has been for PQA! As we continue progress towards completion of our strategic plan, Blueprint PQA 2025, our team has been hard at work alongside our valued members to deliver meaningful improvements and drive positive change in quality medication use.
Adherence to medications for cholesterol, hypertension, and diabetes helped Medicare beneficiaries avoid up to $29.2 billion in healthcare costs over six years (2016-21), according to the 2024 National Impact Assessment of CMS Quality Measures Report. This report underscores the importance of high-impact measures for chronic conditions, as evidence-based management efforts can significantly reduce complications and mortality.
Through convening events, research, pilots and work to develop standard pharmacy quality measures, PQA has been a national leader in advancing pharmacist-provided care. A 2018 PQA-convened task force identified 15 strategies to expand value-based pharmacist-provided care, which form the centerpiece of the 2019 Strategies to Expand Value-Based Pharmacist-Provided Care Action Guide. The guide was designed to spark conversation and foster collaboration between community pharmacy organizations, pharmacists and health care payers.
Oral anticancer medications (OAMs) are a growing and important tool in the fight against cancer. More than 120 FDA-approved OAMs were used in clinical practice in 2022, and OAMs represent more than one-third of cancer medications in the development pipeline.
PQA members and health quality professionals gathered in Baltimore, Md., May 14-16, for the 2024 PQA Annual Meeting.
The 2024 PQA Annual Meeting poster session featured 23 quality improvement and research projects. Sponsored by Pharmacy Quality Solutions, the session provided an opportunity for authors to showcase their work and for attendees to engage in insightful dialogue about healthcare quality.
The upcoming 2024 PQA Annual Meeting's poster session will showcase 23 quality improvement and research projects. Sponsored by Pharmacy Quality Solutions, this session offers authors a platform to exhibit their work and enables attendees to engage in insightful discussions about healthcare quality.
Have you made your plans to attend the 2024 PQA Annual Meeting? This year's meeting will be held in Baltimore from May 14 -16. Early registration ends Friday, April 19; register today to take advantage of the member discount!
